Danette L. Daniels
Foghorn Therapeutics (United States)
12 papers found
Refreshing results…
Target 2035 – an update on private sector contributions
UploadTrivalent PROTACs enhance protein degradation via combined avidity and cooperativity
UploadDiscovery and resistance mechanism of a selective CDK12 degrader
Download from www.nature.comSelective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation
UploadMissing publications? Search for publications with a matching author name.